Quality of care in the New Mexico Medicaid program (1971-1975) : the effect of the New Mexico Experimental Medical Care Review Organization on the use of antibiotics for common infectious diseases

by Kathleen N. Lohr, Robert H. Brook, Michael A. Kaufman, Bryant M. Mori, Caren Kamberg, Larry Miller


Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback136 pages $30.00 $24.00 20% Web Discount

One of a series of publications on the New Mexico Experimental Medical Care Review Organization (EMCRO), this study describes patterns of ambulatory care for common infectious diseases (chiefly respiratory) among participants in the New Mexico Medicaid program. The study investigates (1) the effect of physician characteristics on outpatient care and (2) how physician peer review organization (EMCRO) affects that care, especially the use of injectable drugs. The first part of the study focuses on ambulatory visits and all types of injectable drugs. The second part develops a methodology for defining entire episodes of care for six common respiratory infections; with episodes as the analytic unit, use of both intramuscular and oral antibiotics, laboratory tests, and followup visits was explored. Documented findings include improvements in the use of injectable drugs, especially antibiotics, and differences in quality of care delivered by various physicians. Implications for (1) refining and using episode methodology for insurance claims data and (2) national policies on quality of care assessment and assurance are discussed.

This report is part of the RAND Corporation Report series. The report was a product of the RAND Corporation from 1948 to 1993 that represented the principal publication documenting and transmitting RAND's major research findings and final research.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/research-integrity.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.